Department of Hematology, Ullevål University Hospital, University of Oslo

Oslo 0407

0 studies enrolling now · 1 studies all time

What they study most

AML, Hematologic Malignancies

Studies at this site

• A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies — Completed